Quantcast
Channel: WN.com - Articles related to MedX Health Corp. Announces Its Third Quarter 2015 Financial Results and Approval of Share Issuances
Viewing all articles
Browse latest Browse all 300

MELA Sciences, Inc., A Leader In The Fight Against Melanoma, Hosts Symposium At 8th World Congress Of Melanoma

$
0
0
My news for Investors AtLeast one of the check box should be selected You are following news about Follow the latest news about MELA Download image MELA Sciences. (PRNewsFoto/MELA Sciences, Inc.) IRVINGTON, N.Y., July 22, 2013 /PRNewswire/ -- MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that has developed and is commercializing MelaFind®, the first and only FDA approved optical diagnostic device for melanoma detection used by dermatologists in their fight against melanoma, presented at the 8th World Congress of Melanoma held in Hamburg, Germany, on July 19, 2013, to a well-attended room.     (Logo:...

Viewing all articles
Browse latest Browse all 300

Latest Images

Trending Articles



Latest Images

<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>